NCT05035238View on ClinicalTrials.gov

Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 1, 2021

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Covid19
Interventions
BIOLOGICAL

Triple dose vaccination by inactivated Covid19 vaccine

triple dose intramuscular vaccine on Day 0, Day 28, and Day 120.

Trial Locations (1)

38038

Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP), Kayseri

Sponsors

Collaborators (1)

Mene Research
All Listed Sponsors
collaborator

Mene Research

OTHER

collaborator

TC Erciyes University

OTHER

lead

Health Institutes of Turkey

OTHER_GOV

NCT05035238 - Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial | Biotech Hunter | Biotech Hunter